Publication: KERA (NPR, Dallas-Fort Worth)
A new state law this month made Texas the 11th state to require health insurance companies to pay for biomarker testing.
Doing so will give cancer patients access to more targeted and effective therapies in precision medicine.
KERA’s Sam Baker talks about all this with Dr. Chris Prakash, director of quality services for Texas Oncology and current president of the Texas Society of Clinical Oncology. Prakash helped in efforts to pass Senate Bill 989.
Listen to the full story.